ConductScience.org, home

Gene · 2213

NIH grants2,625

NIH grants whose papers are about the gene, through NIH's grant-paper links.

921 to 940 of 2,625

Download this page as JSON
GrantTitleFCGR2B papersNewest fiscal year
R01DK117597Hemodynamics and hepatic remodeling12021
R01EB026291Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors12021
R01ES027873Gene-Environment Collaboration in Autoimmune Disease12021
R01GM040478Structure and Function of Yeast snRNPs12021
R01HD093773Thrombotic microangiopathy (TMA) associated MODS after stem cell transplantation12021
R01HL136512Complement and CR2/CD21 in the Immune Pathogenesis of HIT12021
R01NS036736Inducible DNA repair in cerebral ischemia12021
R01NS099463CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy12021
R01NS101718Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke12021
R01NS105556Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics12021
R03CA249542B7-H3 CAR T cell-based immunotherapy combined with Losartan to counteract desmoplasia for the treatment of Pancreatic Ductal Adenocarcinoma (PDAC)12021
R21AI144819Determining Enhanced Inflammatory B cell Function in African Americans with MS12021
R21AI147042Universal epitopes-based recombinant influenza vaccines12021
R21AI151497IgE-Independent Mast Cell Activation by Food-Derived Peptides in Eosinophilic Esophagitis (EoE)12021
R21AR076630Modulation of neutrophil function through emperipolesis12021
R21AR076671Parmodulins as an Anti-Resorptive and Anti-Inflammatory Therapy for Metabolic Bone Disease12021
R21AR077842cGAMP as an immunotransmitter of the interferon response to UV light12021
R21AR079661VISTA regulates type I interferon response to ultraviolet light12021
R21ES031510m6A Epitranscriptomics in Toxicant Associated Steatohepatitis12021
R21ES031531Vinyl chloride-induced changes to the epitranscriptome: interaction with diet12021

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2213/grants?page=47